BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15601862)

  • 1. Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras.
    Goeman F; Thormeyer D; Abad M; Serrano M; Schmidt O; Palmero I; Baniahmad A
    Mol Cell Biol; 2005 Jan; 25(1):422-31. PubMed ID: 15601862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
    Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
    Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor ING1 contributes to epigenetic control of cellular senescence.
    Abad M; Moreno A; Palacios A; Narita M; Blanco F; Moreno-Bueno G; Narita M; Palmero I
    Aging Cell; 2011 Feb; 10(1):158-71. PubMed ID: 21078114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressors p33ING1 and p33ING2 interact with alien in vivo and enhance alien-mediated gene silencing.
    Fegers I; Kob R; Eckey M; Schmidt O; Goeman F; Papaioannou M; Escher N; von Eggeling F; Melle C; Baniahmad A
    J Proteome Res; 2007 Nov; 6(11):4182-8. PubMed ID: 17929852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells.
    Tamannai M; Farhangi S; Truss M; Sinn B; Wurm R; Bose P; Henze G; Riabowol K; von Deimling A; Tallen G
    Oncol Res; 2010; 18(10):469-80. PubMed ID: 20681406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor.
    Garkavtsev I; Riabowol K
    Mol Cell Biol; 1997 Apr; 17(4):2014-9. PubMed ID: 9121449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumour suppressor p33ING1 does not enhance camptothecin-induced cell death in melanoma cells.
    Cheung KJ; Li G
    Int J Oncol; 2002 Jun; 20(6):1319-22. PubMed ID: 12012016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the novel tumour suppressor p33(ING1)is independent of p53.
    Cheung KJ; Bush JA; Jia W; Li G
    Br J Cancer; 2000 Dec; 83(11):1468-72. PubMed ID: 11076655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumour suppressor p33ING1 does not regulate migration and angiogenesis in melanoma cells.
    Cheung KJ; Li G
    Int J Oncol; 2002 Dec; 21(6):1361-5. PubMed ID: 12429989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.
    Takahashi M; Seki N; Ozaki T; Kato M; Kuno T; Nakagawa T; Watanabe K; Miyazaki K; Ohira M; Hayashi S; Hosoda M; Tokita H; Mizuguchi H; Hayakawa T; Todo S; Nakagawara A
    Cancer Res; 2002 Apr; 62(8):2203-9. PubMed ID: 11956069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
    Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
    Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of p33ING1 mRNA in lymphoid malignancies.
    Ohmori M; Nagai M; Tasaka T; Koeffler HP; Toyama T; Riabowol K; Takahara J
    Am J Hematol; 1999 Oct; 62(2):118-9. PubMed ID: 10577281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells.
    Tallen G; Riabowol K; Wolff JE
    Anticancer Res; 2003; 23(2B):1631-5. PubMed ID: 12820433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK.
    Chang HC; Liu LT; Hung WC
    Cell Signal; 2004 Jun; 16(6):675-9. PubMed ID: 15093608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines.
    Campos EI; Cheung KJ; Murray A; Li S; Li G
    Br J Dermatol; 2002 Apr; 146(4):574-80. PubMed ID: 11966686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.
    Garkavtsev I; Kazarov A; Gudkov A; Riabowol K
    Nat Genet; 1996 Dec; 14(4):415-20. PubMed ID: 8944021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1).
    Garkavtsev I; Demetrick D; Riabowol K
    Cytogenet Cell Genet; 1997; 76(3-4):176-8. PubMed ID: 9186514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional link between the tumour suppressors ARF and p33ING1.
    González L; Freije JM; Cal S; López-Otín C; Serrano M; Palmero I
    Oncogene; 2006 Aug; 25(37):5173-9. PubMed ID: 16607280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.